Literature DB >> 34272320

PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?

Winfried Brenner1,2, Joachim Strobel3, Vikas Prasad2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34272320      PMCID： PMC8882903          DOI： 10.2967/jnumed.121.262737

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  15 in total

1.  Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas.

Authors:  Roberto Andres Salas Fragomeni; Joshua R Menke; Matthias Holdhoff; Clare Ferrigno; John Joseph Laterra; Lilja B Solnes; Mehrbod S Javadi; Zsolt Szabo; Martin G Pomper; Steven P Rowe
Journal:  Clin Nucl Med       Date:  2017-10       Impact factor: 7.794

2.  18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.

Authors:  Fahad Marafi; Arun Sasikumar; Wael Fathallah; Abdulredh Esmail
Journal:  Clin Nucl Med       Date:  2020-01       Impact factor: 7.794

3.  A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.

Authors:  Michael S Hofman; Declan G Murphy; Scott G Williams; Tatenda Nzenza; Alan Herschtal; Richard De Abreu Lourenco; Dale L Bailey; Ray Budd; Rodney J Hicks; Roslyn J Francis; Nathan Lawrentschuk
Journal:  BJU Int       Date:  2018-06-03       Impact factor: 5.588

4.  Uptake of Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL in Cerebral Radionecrosis: Implications for Diagnostic Imaging of High-Grade Gliomas.

Authors:  Roberto A Salas Fragomeni; Kenneth J Pienta; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Clin Nucl Med       Date:  2018-11       Impact factor: 7.794

5.  Utility of 68Ga-PSMA-11 PET/CT in Imaging of Glioma-A Pilot Study.

Authors:  Arun Sasikumar; Raghava Kashyap; Ajith Joy; Kanhu Charan Patro; Parthasarathy Bhattacharya; Venkata Krishna Reddy Pilaka; Karuna Elza Oommen; Maroor Raghavan Ambikalmajan Pillai
Journal:  Clin Nucl Med       Date:  2018-09       Impact factor: 7.794

6.  Accuracy of 68Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer.

Authors:  Maija Radzina; Mara Tirane; Lilita Roznere; Liene Zemniece; Laura Dronka; Marika Kalnina; Edgars Mamis; Juergen Biederer; Vilnis Lietuvietis; Arvis Freimanis; Egils Vjaters
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-04-15

7.  Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST.

Authors:  Birthe Heitkötter; Marcel Trautmann; Inga Grünewald; Martin Bögemann; Kambiz Rahbar; Heidrun Gevensleben; Eva Wardelmann; Wolfgang Hartmann; Konrad Steinestel; Sebastian Huss
Journal:  Oncotarget       Date:  2017-01-17

Review 8.  Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings.

Authors:  Felipe de Galiza Barbosa; Marcelo Araujo Queiroz; Rafael Fernandes Nunes; Larissa Bastos Costa; Elaine Caroline Zaniboni; José Flavio Gomes Marin; Giovanni Guido Cerri; Carlos Alberto Buchpiguel
Journal:  Cancer Imaging       Date:  2020-03-14       Impact factor: 3.909

9.  PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging.

Authors:  Adrien Holzgreve; Annamaria Biczok; Viktoria C Ruf; Friederike Liesche-Starnecker; Katja Steiger; Maximilian A Kirchner; Marcus Unterrainer; Lena Mittlmeier; Jochen Herms; Jürgen Schlegel; Peter Bartenstein; Jörg-Christian Tonn; Nathalie L Albert; Bogdana Suchorska
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

10.  Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Authors:  Michael S Hofman; Nathan Lawrentschuk; Roslyn J Francis; Colin Tang; Ian Vela; Paul Thomas; Natalie Rutherford; Jarad M Martin; Mark Frydenberg; Ramdave Shakher; Lih-Ming Wong; Kim Taubman; Sze Ting Lee; Edward Hsiao; Paul Roach; Michelle Nottage; Ian Kirkwood; Dickon Hayne; Emma Link; Petra Marusic; Anetta Matera; Alan Herschtal; Amir Iravani; Rodney J Hicks; Scott Williams; Declan G Murphy
Journal:  Lancet       Date:  2020-03-22       Impact factor: 79.321
View more
  1 in total

1.  [68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma.

Authors:  Peter Truckenmueller; Josefine Graef; Michael Scheel; Peter Vajkoczy; David Capper; David Kaul; Christian Furth; Holger Amthauer; Winfried Brenner; Julia Sophie Onken
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.